These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 32980695)
1. Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts. Lin Y; Wang M; Jia J; Wan W; Wang T; Yang W; Li C; Chen X; Cao H; Zhang P; Tao K EBioMedicine; 2020 Oct; 60():103016. PubMed ID: 32980695 [TBL] [Abstract][Full Text] [Related]
2. [A model to predict the recurrence of middle-high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes]. Li W; Peng QW; Lin Y; Wan WZ; Zeng XY; Sun X; Yang WC; Xiong Z; Liu WZ; Tao KX; Zhang P Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):896-903. PubMed ID: 32927515 [No Abstract] [Full Text] [Related]
3. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Gold JS; Gönen M; Gutiérrez A; Broto JM; García-del-Muro X; Smyrk TC; Maki RG; Singer S; Brennan MF; Antonescu CR; Donohue JH; DeMatteo RP Lancet Oncol; 2009 Nov; 10(11):1045-52. PubMed ID: 19793678 [TBL] [Abstract][Full Text] [Related]
4. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods. Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a nomogram based on CT images and 3D texture analysis for preoperative prediction of the malignant potential in gastrointestinal stromal tumors. Ren C; Wang S; Zhang S Cancer Imaging; 2020 Jan; 20(1):5. PubMed ID: 31931874 [TBL] [Abstract][Full Text] [Related]
6. Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors. Racz JM; Cleghorn MC; Jimenez MC; Atenafu EG; Jackson TD; Okrainec A; Venkat Raghavan L; Quereshy FA Ann Surg Oncol; 2015 Jul; 22(7):2343-50. PubMed ID: 25472648 [TBL] [Abstract][Full Text] [Related]
7. Fibrinogen/Albumin Ratio Index Is an Independent Prognosis Predictor of Recurrence-Free Survival in Patients After Surgical Resection of Gastrointestinal Stromal Tumors. Cao X; Cui J; Yu T; Li Z; Zhao G Front Oncol; 2020; 10():1459. PubMed ID: 33014783 [No Abstract] [Full Text] [Related]
8. Immune-infiltration based signature as a novel prognostic biomarker in gastrointestinal stromal tumour. Wei ZW; Wu J; Huang WB; Li J; Lu XF; Yuan YJ; Xiong WJ; Zhang XH; Wang W; He YL; Zhang CH EBioMedicine; 2020 Jul; 57():102850. PubMed ID: 32574962 [TBL] [Abstract][Full Text] [Related]
9. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892 [TBL] [Abstract][Full Text] [Related]
10. Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis. Tanimine N; Tanabe K; Suzuki T; Tokumoto N; Ohdan H World J Surg Oncol; 2012 Feb; 10():43. PubMed ID: 22348408 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Nomogram for Gastrointestinal Stromal Tumors after Surgery Based on the SEER Database. Sun Q; Chen Y; Li T; Zhu X; Zhu G; Ni B; Gao R; Li J Biomed Res Int; 2022; 2022():5639174. PubMed ID: 36420093 [TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma. Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782 [TBL] [Abstract][Full Text] [Related]
13. Risk stratification systems for surgically treated localized primary Gastrointestinal Stromal Tumors (GIST). Review of literature and comparison of the three prognostic criteria: MSKCC Nomogramm, NIH-Fletcher and AFIP-Miettinen. Belfiori G; Sartelli M; Cardinali L; Tranà C; Bracci R; Gesuita R; Marmorale C Ann Ital Chir; 2015; 86(3):219-27. PubMed ID: 26098671 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib. Lee CK; Goldstein D; Gibbs E; Joensuu H; Zalcberg J; Verweij J; Casali PG; Maki RG; Cioffi A; Mcarthur G; Lord SJ; Yip D; Kanjanapan Y; Rutkowski P Eur J Cancer; 2015 May; 51(7):852-60. PubMed ID: 25801699 [TBL] [Abstract][Full Text] [Related]
15. Novel Prognostic Nomogram for Recurrence-Free Survival of Patients With Primary Gastrointestinal Stromal Tumors After Surgical Resection: Combination of Prognostic Nutritional Index and Basic Variables. Li S; Chen D; Li S; Zhao Z; Yang H; Wang D; Zhang Z; Fu W Front Oncol; 2020; 10():581855. PubMed ID: 33585198 [TBL] [Abstract][Full Text] [Related]
16. Developed and validated a prognostic nomogram for recurrence-free survival after complete surgical resection of local primary gastrointestinal stromal tumors based on deep learning. Chen T; Liu S; Li Y; Feng X; Xiong W; Zhao X; Yang Y; Zhang C; Hu Y; Chen H; Lin T; Zhao M; Liu H; Yu J; Xu Y; Zhang Y; Li G EBioMedicine; 2019 Jan; 39():272-279. PubMed ID: 30587460 [TBL] [Abstract][Full Text] [Related]
17. A nomogram to predict disease-free survival after surgical resection of GIST. Bischof DA; Kim Y; Behman R; Karanicolas PJ; Quereshy FA; Blazer DG; Maithel SK; Gamblin TC; Bauer TW; Pawlik TM J Gastrointest Surg; 2014 Dec; 18(12):2123-9. PubMed ID: 25245766 [TBL] [Abstract][Full Text] [Related]
18. Sarcopenia as a novel prognostic factor in the patients of primary localized gastrointestinal stromal tumor. Song H; Xiao X; Liu G; Zhou J BMC Cancer; 2022 Feb; 22(1):179. PubMed ID: 35177018 [TBL] [Abstract][Full Text] [Related]
19. Development and external validation of a nomogram for individualized adjuvant imatinib duration for high-risk gastrointestinal stromal tumors: A multicenter retrospective cohort study. Liu R; Wu Y; Gong J; Zhao R; Li L; Wan Q; Lian N; Shen X; Xia L; Shen Y; Xiao H; Wu X; Chen Y; Cen Y; Xu X Cancer Med; 2022 Aug; 11(16):3093-3105. PubMed ID: 35297216 [TBL] [Abstract][Full Text] [Related]
20. Establishment and Verification of Prognostic Nomograms for Patients with Gastrointestinal Stromal Tumors: A SEER-Based Study. Chen Z; Lin RM; Bai YK; Zhang Y Biomed Res Int; 2019; 2019():8293261. PubMed ID: 31032364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]